Investment
Participated in Beren Therapeutics' $300M financing package to support the potential commercial launch of adrabetadex.
Beren Therapeutics
Every public signal F4 has attached to this firm, with sources and cross-entity links.
Beren Therapeutics
True Anomaly
Chapter